Search results
Van ECK Associates Corp Sells 9,078 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 22 hours agoVan ECK Associates Corp trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent ...
Exact Sciences CEO acquires shares, sells for $69k to cover taxes By Investing.com
Investing.com· 1 day agoExact Sciences Corp (NASDAQ:EXAS) President and CEO Kevin T. Conroy engaged in recent stock...
Exact Sciences CCO buys shares worth $21,254, sells for $8,180 By Investing.com
Investing.com· 1 day agoEverett Cunningham, the Chief Commercial Officer of Exact Sciences Corp (NASDAQ:EXAS), has recently...
Exact sciences CFO buys $21.2k in stock, sells $8.2k By Investing.com
Investing.com· 1 day agoExact Sciences Corp. (NASDAQ:EXAS) Chief Financial Officer Jeffrey Thomas Elliott has recently...
Exact sciences EVP sells shares worth $6,616 By Investing.com
Investing.com· 1 day agoIn a recent move by a top executive at Exact Sciences Corp (NASDAQ:EXAS), EVP and General Manager of...
Exact Sciences director sells $4,030 in stock By Investing.com
Investing.com· 1 day agoD. Scott Coward, a director at Exact Sciences Corp (NASDAQ:EXAS), has sold a total of 67 shares of...
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by California Public Employees Retirement System
ETF DAILY NEWS· 5 days agoCalifornia Public Employees Retirement System lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.0% in the fourth quarter, according to ...
Exact Sciences EVP sells $6,135 in stock, buys $21,254 worth By Investing.com
Investing.com· 1 day agoIn a recent transaction, Sarah Condella, the EVP of Human Resources at Exact Sciences Corp (NASDAQ:...
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
Zacks· 3 days agoFree Report) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.46 per share. This quarterly report represents an earnings surprise of 4.35%. Over ...
GenomeWeb Top 40 Down 8 Percent in April, Following Broader Market
GenomeWeb News· 3 days agoThe Dow Jones Industrial Average lost 5 percent, the Nasdaq lost 4 percent, and the Nasdaq Biotech Index lost 6 percent last month.
